Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
CRISPR (2)
48 Articles Available
2
2
Can't find what you're looking for? Try our
advanced search
.
CRISPR
CRISPR-Chip Enables Digital Detection of DNA Without Amplification
PR-M03-19-NI-076
CRISPR-Cas9
University of California Granted New CRISPR-Cas9 Patent, Extending its Patent Portfolio for Genome Editing
PR-M03-19-NI-040
CRISPR
MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M03-19-NI-009
CRISPR
Gene Amplification Controls Obesity in Mice
PAO-M12-18-NI-018
CRISPR
CRISPR Used to Edit Genes in Human Embryos
PAO-M11-18-NI-024
CRISPR
CRISPR Technology Market Worth $1,715 Million by 2023 - Exclusive Report by MarketsandMarkets™
PR-M11-18-NI-083
Cell and Gene Therapy
Gene that Helps Cells Resist Zika Infection Identified
PAO-M09-18-NI-018
CRISPR
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M09-18-NI-046
CRISPR
CRISPR is Helping Dogs with Muscular Dystrophy and Young Boys Could be Next
PAO-M08-18-NI-030
Collaboration
Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101
PR-M08-18-NI-062
Acquisition
Locus Biosciences acquires EpiBiome's high-throughput discovery platform to enhance its global leadership in CRISPR-engineered phage therapeutics
PR-M07-18-NI-060
CRISPR
New Diagnostic Tool for Heart Disease Based on CRISPR Technology
PAO-M06-18-NI-016
Cell and Gene Therapy
Editas Founders Start New Gene Editing Company
PAO-M05-18-NI-011
CRISPR
CRISPR Gene Editing Technology Could Eliminate the Need for Hemophilia B Sufferers to Receive Ongoing Injections
PAO-M05-18-NI-007
Expansion
Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics
PR-M05-18-NI-023
CRISPR
MilliporeSigma Receives Two More Patents for CRISPR Technology
PR-M02-18-NI-86
CRISPR
Genetically Engineered Horses Could be a Reality
PAO-M01-18-NI-008
CRISPR
Charles River Expands CRISPR Offerings with Second License
PAO-M12-17-NI-022
Gene Editing
Excision BioTherapeutics Licenses UC Berkeley CRISPR Systems
PAO-M11-17-NI-046
CRISPR
CRISPR Technology Could Enable New Treatments for Resistant Fungal Infections
PAO-M11-17-NI-006
Acquisition
Horizon Discovery Acquires GE CRISPR Unit for $85 Million
PAO-M08-17-NI-002
Innovation
Can Cells Replace Computers?
PAO-M07-17-NI-027
CRISPR
MilliporeSigma Increases the Efficiency of Gene Editing
PAO-M05-17-NI-030
The Diagnostic Promise: Screening with CRISPR to Detect the Zika Virus and More
PAO-M04-17-NI-021
«
2
2